If a bid is made, which I expect, the current 22.5p share price will2 May 2023 12:59
be looked back on as a complete joke. Any offer IMHO would have to be double the existsting sp, and probably more.
Remember the last placing was at 80p a share, and the market supported it obviously or it could not have been done. Why did the market finance the placing at 80p? The current sp is 22.5p !!!!!!!!!!!!!!!!!!!!
Am I mad or its the market missing something here?
Surely the Pharma Co's simply must be interested in the FDA approved machine (meaning it is authorised for use in the USA). The only one in the World that can separate a LIVE cancerous blood cell from a blood sample for analysys. Because a cancer can change over time (meaning the treatment might need changing) the machine enables the cancer to be monitored for any changes. Obviously blood samples can be taken as and when needed for analysis.
All IMHO.